I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 29 studies | 37% ± 17% | |
| macrophage | 28 studies | 30% ± 12% | |
| fibroblast | 22 studies | 31% ± 10% | |
| classical monocyte | 19 studies | 27% ± 8% | |
| conventional dendritic cell | 16 studies | 25% ± 9% | |
| mast cell | 14 studies | 25% ± 9% | |
| non-classical monocyte | 14 studies | 28% ± 10% | |
| dendritic cell | 12 studies | 32% ± 13% | |
| monocyte | 12 studies | 36% ± 10% | |
| type I pneumocyte | 12 studies | 62% ± 19% | |
| type II pneumocyte | 12 studies | 36% ± 15% | |
| vein endothelial cell | 12 studies | 36% ± 15% | |
| plasmacytoid dendritic cell | 10 studies | 26% ± 11% | |
| endothelial cell of artery | 10 studies | 26% ± 10% | |
| endothelial cell of vascular tree | 10 studies | 51% ± 18% | |
| capillary endothelial cell | 9 studies | 31% ± 9% | |
| pericyte | 8 studies | 25% ± 4% | |
| myeloid cell | 8 studies | 33% ± 14% | |
| mononuclear phagocyte | 5 studies | 33% ± 11% | |
| basal cell | 5 studies | 24% ± 5% | |
| club cell | 5 studies | 32% ± 21% | |
| neutrophil | 4 studies | 33% ± 12% | |
| natural killer cell | 4 studies | 22% ± 6% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 31% ± 6% | |
| secretory cell | 4 studies | 25% ± 7% | |
| connective tissue cell | 4 studies | 29% ± 8% | |
| tissue-resident macrophage | 3 studies | 40% ± 22% | |
| intermediate monocyte | 3 studies | 32% ± 15% | |
| monocyte-derived dendritic cell | 3 studies | 24% ± 7% | |
| smooth muscle cell | 3 studies | 19% ± 2% | |
| leukocyte | 3 studies | 24% ± 3% | |
| ciliated cell | 3 studies | 26% ± 6% |
